what's better zepbound or semaglutide So, here's a quick breakdown: (Wegovy/Ozempic) is a GLP-1 receptor agonist — it mimics a gut hormone that regulates appetite and blood sugar. Tirzepatide (Zepbound/Mounjaro) is a dual GIP/GLP-1 agonist — Zepbound vs. Wegovy: Difference Between

Additionally, if gastrointestinal side effects (nausea or constipation) have fully resolved and you tolerate your medication well, your body is signaling readiness for more stimulus

2022 Mar;16(3):102427

For researchers and clinicians, the approval reinforces the idea that these therapies could play a broader role in tackling metabolic diseases

Poor sleep may compound the muscle-loss risk on GLP-1 therapy Kion Sleep here Consider a blood panel To rule out iron deficiency, B12 depletion, or vitamin D insufficiency as contributing factors A Note on Rate of Weight Loss Very rapid weight loss on GLP-1 medications (more than 11.5 pounds per week on average) significantly increases the proportion of lean mass lost